301 related articles for article (PubMed ID: 34407393)
1. Icariin ameliorate Alzheimer's disease by influencing SIRT1 and inhibiting Aβ cascade pathogenesis.
Chuang Y; Van I; Zhao Y; Xu Y
J Chem Neuroanat; 2021 Nov; 117():102014. PubMed ID: 34407393
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological Effects of Active Components of Chinese Herbal Medicine in the Treatment of Alzheimer's Disease: A Review.
Wang ZY; Liu JG; Li H; Yang HM
Am J Chin Med; 2016; 44(8):1525-1541. PubMed ID: 27848250
[TBL] [Abstract][Full Text] [Related]
3. Icariin inhibits neurotoxicity of beta-amyloid by upregulating cocaine-regulated and amphetamine-regulated transcripts.
Sha D; Li L; Ye L; Liu R; Xu Y
Neuroreport; 2009 Nov; 20(17):1564-7. PubMed ID: 19858766
[TBL] [Abstract][Full Text] [Related]
4. The Combination of
Wang N; Wang H; Pan Q; Kang J; Liang Z; Zhang R
Oxid Med Cell Longev; 2021; 2021():7158444. PubMed ID: 34887998
[No Abstract] [Full Text] [Related]
5. Icariin attenuates β-amyloid-induced neurotoxicity by inhibition of tau protein hyperphosphorylation in PC12 cells.
Zeng KW; Ko H; Yang HO; Wang XM
Neuropharmacology; 2010 Nov; 59(6):542-50. PubMed ID: 20708632
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
7. Multi-Target Strategy and Experimental Studies of Traditional Chinese Medicine for Alzheimer's Disease Therapy.
Li L; Zhang L; Yang CC
Curr Top Med Chem; 2016; 16(5):537-48. PubMed ID: 26268330
[TBL] [Abstract][Full Text] [Related]
8. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
Pinheiro L; Faustino C
Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
[TBL] [Abstract][Full Text] [Related]
10. Notopterygium incisum extract (NRE) rescues cognitive deficits in APP/PS1 Alzhneimer's disease mice by attenuating amyloid-beta, tau, and neuroinflammation pathology.
Jiang XW; Liu WW; Wu YT; Wu Q; Lu HY; Xu ZH; Gao HY; Zhao QC
J Ethnopharmacol; 2020 Mar; 249():112433. PubMed ID: 31783135
[TBL] [Abstract][Full Text] [Related]
11. NeuroDefend, a novel Chinese medicine, attenuates amyloid-β and tau pathology in experimental Alzheimer's disease models.
Iyaswamy A; Krishnamoorthi SK; Song JX; Yang CB; Kaliyamoorthy V; Zhang H; Sreenivasmurthy SG; Malampati S; Wang ZY; Zhu Z; Tong BC; Cheung KH; Lu JH; Durairajan SSK; Li M
J Food Drug Anal; 2020 Jan; 28(1):132-146. PubMed ID: 31883601
[TBL] [Abstract][Full Text] [Related]
12. Icariin decreases both APP and Aβ levels and increases neurogenesis in the brain of Tg2576 mice.
Li F; Dong HX; Gong QH; Wu Q; Jin F; Shi JS
Neuroscience; 2015 Sep; 304():29-35. PubMed ID: 26079110
[TBL] [Abstract][Full Text] [Related]
13. Icariin inhibits beta-amyloid peptide segment 25-35 induced expression of beta-secretase in rat hippocampus.
Nie J; Luo Y; Huang XN; Gong QH; Wu Q; Shi JS
Eur J Pharmacol; 2010 Jan; 626(2-3):213-8. PubMed ID: 19782061
[TBL] [Abstract][Full Text] [Related]
14. Icariin, a major constituent of flavonoids from Epimedium brevicornum, protects against cognitive deficits induced by chronic brain hypoperfusion via its anti-amyloidogenic effect in rats.
Li WX; Deng YY; Li F; Liu B; Liu HY; Shi JS; Gong QH
Pharmacol Biochem Behav; 2015 Nov; 138():40-8. PubMed ID: 26364923
[TBL] [Abstract][Full Text] [Related]
15. Formulated Chinese medicine Shaoyao Gancao Tang reduces NLRP1 and NLRP3 in Alzheimer's disease cell and mouse models for neuroprotection and cognitive improvement.
Chiu YJ; Lin CH; Lee MC; Hsieh-Li HM; Chen CM; Wu YR; Chang KH; Lee-Chen GJ
Aging (Albany NY); 2021 Jun; 13(11):15620-15637. PubMed ID: 34106880
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
Götz J; Schild A; Hoerndli F; Pennanen L
Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
[TBL] [Abstract][Full Text] [Related]
17. Icariin decreases the expression of APP and BACE-1 and reduces the β-amyloid burden in an APP transgenic mouse model of Alzheimer's disease.
Zhang L; Shen C; Chu J; Zhang R; Li Y; Li L
Int J Biol Sci; 2014; 10(2):181-91. PubMed ID: 24550686
[TBL] [Abstract][Full Text] [Related]
18.
Wang Z; Yang Y; Liu M; Wei Y; Liu J; Pei H; Li H
Curr Vasc Pharmacol; 2020; 18(4):358-368. PubMed ID: 31291876
[TBL] [Abstract][Full Text] [Related]
19. The Effect of TCM-Induced HAMP on Key Enzymes in the Hydrolysis of AD Model Cells.
Xian-Hui D; Dong-Xue M; Tian-Ci Z; Xiao-Ping H; Li-Jun X; Ya-Lei L; Hao L; Wei-Juan G
Neurochem Res; 2021 May; 46(5):1068-1080. PubMed ID: 33683629
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
Behl T; Kaur I; Fratila O; Brata R; Bungau S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
